Stage Two, Randomized Review associated with Ketorolac (PDR001), a good Anti-PD-1 Antibody, Compared to Chemotherapy inside People With Recurrent/Metastatic Nasopharyngeal Cancers. Website: https://en.wikipedia.org/wiki/Ketorolac